Association of Heterogeneous Circulating Biomarkers and Anamnestic Factors of Pregnancy Adverse Course and Outcomes With the Prognosis of Heart Failure With Preserved Ejection Fraction
National Medical Research Center for Therapy and Preventive Medicine
Age
60–74
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women aged 60-74 years
Heart failure with preserved ejection fraction (diagnosed by using HFA-PEFF algorithm)
History of pregnancy with duration at least 20 weeks
Willing and legally able to sign informed consent
You may not be if
History of ejection fraction less than 50% diagnosed by echocardiography
Diagnosed cognitive impairment or dementia
The state of cardiovascular disease decompensation
Exacerbation of comorbidities
The presence of chronic diseases that may affect the results of the study: ischemic heart disease (unstable angina, stable effort angina III-IV grade, previous myocardial infarction), previous Ischemic/hemorrhagic stroke, severe valvular heart diseases, cardiomyopathy, myocarditis, uncontrolled bronchial asthma or chronic obstructive pulmonary disease, terminal chronic kidney disease requiring dialysis, implanted pacemaker (including cardiac resynchronisation device, or defibrillator), active cancer, history of chemotherapy or radiation therapy to the chest area
Clareo Health | Association of Heterogeneous Circulating Biomarkers and Anamnestic Factors of Pregnancy Adverse Course and Outcomes With the Prognosis of Heart Failure With Preserved Ejection Fraction
